MK, T., & AM, A. (2019). Cardioprotective effect of ranolazine in nondiabetic and diabetic male rats subjected to isoprenaline-induced acute myocardial infarction involves modulation of AMPK and inhibition of apoptosis. Canadian journal of physiology and pharmacology, 97(7), 661. https://doi.org/10.1139/cjpp-2018-0571
Chicago Style (17th ed.) CitationMK, Tawfik, and Ameen AM. "Cardioprotective Effect of Ranolazine in Nondiabetic and Diabetic Male Rats Subjected to Isoprenaline-induced Acute Myocardial Infarction Involves Modulation of AMPK and Inhibition of Apoptosis." Canadian Journal of Physiology and Pharmacology 97, no. 7 (2019): 661. https://doi.org/10.1139/cjpp-2018-0571.
MLA (9th ed.) CitationMK, Tawfik, and Ameen AM. "Cardioprotective Effect of Ranolazine in Nondiabetic and Diabetic Male Rats Subjected to Isoprenaline-induced Acute Myocardial Infarction Involves Modulation of AMPK and Inhibition of Apoptosis." Canadian Journal of Physiology and Pharmacology, vol. 97, no. 7, 2019, p. 661, https://doi.org/10.1139/cjpp-2018-0571.
